Dissociation of humoral and cellular immune responses in kidney transplant recipients with EBV mucocutaneous ulcer
Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of hematological malignancies occurring in immunocompromised patients following both solid organ and hematopoietic stem cells transplantation. 1 Among them, EBV-positive mucocutaneous ulcer (EBV-MCU) is a rare EBV-positive B-cell lymphoproliferative disorder recently recognized in the 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms. 2 This rare condition often presents as an isolated and circumscribed cutaneous
Keywords
Immunosuppressive treatment
MMF
Mycofenolate mofetil
PTLD
Post-transplant lymphoproliferative disorder
WHO
EBV-MCU
EBV-positive mucocutaneous ulcer IST
Immunosuppressive treatment MMF
Mycofenolate mofetil PTLD
Post-transplant lymphoproliferative disorder WHO
World Health Organization dissociated immune response
EBV positive mucocutaneous ulcer
Epstein-Barr virus
Posttransplant lymphoproliferative disorder
EBV-positive mucocutaneous ulcer
IST